Full metadata record
DC FieldValueLanguage
dc.creatorRaquel-
dc.creatorEstévez-Vázquez, O. (Olga)-
dc.creatorFlores-Perojo, V. (Vicente)-
dc.creatorMacías-Rodríguez, R.U. (Ricardo U.)-
dc.creatorRuiz-Margáin, A. (Astrid)-
dc.creatorMartínez-Naves, E. (Eduardo)-
dc.creatorRegueiro, J.R. (José Ramón)-
dc.creatorAvila, M.A. (Matías Antonio)-
dc.creatorTrautwein, C. (Christian)-
dc.creatorBañares, R. (Rafael)-
dc.creatorBosch, J. (Jaume)-
dc.creatorCubero, F.J. (Francisco Javier)-
dc.creatorNevzorova, Y. (Yulia)-
dc.date.accessioned2021-10-06T07:25:42Z-
dc.date.available2021-10-06T07:25:42Z-
dc.date.issued2021-
dc.identifier.citationBenede Ubieto, R.; Estevez Vazquez, O.; Flores Perojo, V.; et al. "Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain". Journal of Clinical Medicine. 10 (5), 2021, 1039es
dc.identifier.issn2077-0383-
dc.identifier.urihttps://hdl.handle.net/10171/62153-
dc.description.abstractThe outbreak of the novel coronavirus SARS-CoV-2 epidemic has rapidly spread and still poses a serious threat to healthcare systems worldwide. In the present study, electronic medical records containing clinical indicators related to liver injury in 799 COVID-19-confirmed patients admitted to a hospital in Madrid (Spain) were extracted and analyzed. Correlation between liver injury and disease outcome was also evaluated. Serum levels of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Gamma-glutamyltransferase (GGT), Alkaline phosphatase (ALP), Lactate dehydrogenase (LDH) and AST/ALT ratio were elevated above the Upper Limit of Normal (ULN) in 25.73%, 49.17%, 34.62%, 24.21%, 55.84% and 75% of patients, respectively. Interestingly, significant positive correlation between LDH levels and the AST/ALT ratio with disease outcome was found. Our data showed that SARS-CoV-2 virus infection leads to mild, but significant changes in serum markers of liver injury. The upregulated LDH levels as well as AST/ALT ratios upon admission may be used as additional diagnostic characteristic for COVID-19 patients.-
dc.description.sponsorshipThis article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/)-
dc.description.sponsorshipThis work was supported by CIBERehd; grant PI16/01126 from Instituto de Salud Carlos III (ISCIII) co-financed by “Fondo Europeo de Desarrollo Regional” (FEDER) “Una manera de hacer Europa”; grant 58/17 from Gobierno de Navarra; the MINECO Retos SAF2014-54708-R, SAF2016- 78711, SAF2017-87919-R, EXOHEP-CM S2017/BMD-3727, NanoLiver-CM Y2018/NMT-4949, ERAB Ref. EA 18/14, AMMF 2018/117, UCM 25/2019, COST Action CA17112, the German Research Foundation (SFB/TRR57/P04, SFB 1382-403224013/A02 and DFG NE 2128/2-1). FJC and YAN are Ramón y Cajal Researchers RYC-2014-15242 and RYC-2015-17438, respectively. RBU is funded by the CT82/20-CT83/20 predoctoral programme UCM/Santander Universidades and OEV is an FPI associated to SAF2017-87919-R. FJC is a Gilead Liver Research Scholar. The research group belongs to the validated Research Groups Ref. 970935 ̈Liver Pathophysiology ̈and 920631 ̈Lymphocyte immunobiology ̈and IBL-6 (imas12-associated).-
dc.language.isoen-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectSARS-CoV-2-
dc.subjectLiver injury-
dc.subjectPandemic-
dc.subjectAST-
dc.subjectALT ratio-
dc.subjectFerritin-
dc.titleAbnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain-
dc.typeinfo:eu-repo/semantics/article-
dc.identifier.doi10.3390/jcm10051039-
dadun.citation.number5-
dadun.citation.publicationNameJournal of Clinical Medicine-
dadun.citation.startingPage1039-
dadun.citation.volume10-

Files in This Item:
Thumbnail
File
pdf.pdf
Description
Size
3.36 MB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.